DOCSLIB.ORG

Poly(L-Alanine) As a Universal Reference Material for Understanding Protein Energies and Structures TERESA HEAD-GORDON, FRANK H

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Poly(L-Alanine) As a Universal Reference Material for Understanding Protein Energies and Structures TERESA HEAD-GORDON, FRANK H Proc. Nati. Acad. Sci. USA Vol. 89, pp. 11513-11517, December 1992 Biophysics Poly(L-alanine) as a universal reference material for understanding protein energies and structures TERESA HEAD-GORDON, FRANK H. STILLINGER, MARGARET H. WRIGHT, AND DAVID M. GAY AT&T Bell Laboratories, Murray Hill, NJ 07974 Contributed by Frank H. Stillinger, June 17, 1992 ABSTRACT We present a proposition, the "poly(L- alanine) hypothesis," which asserts that the native backbone geometry for any polypeptide or protein of M residues has a closely mimicking, mechanically stable, image in poly(L- POLY-L-ALANINE alanine) of the same number of residues. Using a molecular co mechanics force field to represent the relevant potential energy a: hypersurfaces, we have carried out calculations over a wide z range of M values to show that poly(L-alanine) possesses the w structural versatility necessary to satisfy the proposition. These w include poly(L-alanine) representatives of minima correspond- U- ing to secondary and supersecondary structures, as well as PROTEIN poly(L-alanine) images for tertiary structures of the naturally occurring proteins bovine pancreatic trypsin inhibitor, crambin, ribonuclease A, and superoxide dismutase. The suc- cessful validation of the hypothesis presented in this paper BACKBONE COORDINATES indicates that poly(L-alanine) will serve as a good reference FIG. 1. Topographic basis ofthe poly(L-alanine) hypothesis. Free material in thermodynamic perturbation theory and calcula- energy hypersurfaces are compared for a given protein and for tions aimed at evaluating relative free energies for competing poly(L-alanine) with the same number of residues. candidate tertiary structures in real polypeptides and proteins. structure. A third advantage, as explained in Section 4, is that the hypothesis provides a context in which the specific Section 1: Introduction structural roles of disulfide bonds, charged side chains, In this paper we present an idea, the "poly(L-alanine) hy- packing of amino acid side chains, and special residues such pothesis," for the purpose of offering an independent ap- as proline and glycine can be independently and quantita- proach to understanding protein structure and energetics. It tively assessed. asserts that there is a close correspondence, or short-distance A variety of calculations has been undertaken to demon- mapping, between the backbone geometry at the native- strate the validity of the poly(L-alanine) hypothesis. These structure free-energy minimum for any polypeptide or pro- calculations range in M, the number of residues, from very tein of M residues and that of a (metastable) minimum of small to quite large polypeptides and demonstrate the ability poly(L-alanine) of the same number of residues. Fig. 1 of poly(L-alanine) to adopt an impressive repertoire of struc- illustrates this concept. Alanine is the most natural choice of tural alternatives. This diversity is evident even at the dimer residue for such a comprehensive comparison because its level (4). Using larger oligomers, we have demonstrated degree of geometric plasticity, as measured by a Ramachan- stability for representative secondary structures (helices, dran plot (1), is most representative ofall amino acids except turns, sheets), for supersecondary conformers, and for ter- glycine and proline. Furthermore it is the simplest chiral tiary structures exhibited by several naturally occurring residue. Notice that inverse correspondences are not postu- proteins. lated: for steric reasons the global free energy minimum for (L-Ala)M may have no close image among the local minima for Section 2: Methods the free-energy function of a given M-residue protein. Several conceptual advantages arise from successful val- Potential Energy Functions. The empirical potential energy idation of the poly(L-alanine) hypothesis. One is that me- function used has the typical molecular mechanics form and chanical stability of protein native structures do not depend has been described elsewhere (4). We have used the param- on side-chain details but that absolute energy (or free energy) stability is indeed controlled by those details. In this con- eters ofboth the all-atom representation (5) and the extended- nection Matthews and coworkers' (2, 3) T4-lysozyme muta- atom representation (version 19) ofCHARMM (6). For reasons genesis studies have a special significance, wherein replace- of expediency, the all-atom representation (5) has been used ment of several residues by L-alanine has been demonstrated for the cases where the polypeptide has 10 amino acids or to preserve native structure. A second advantage is that fewer; in all other cases the extended-atom representation poly(L-alanine) can serve as a natural reference material in was used (6). For the smaller cases we have also used methyl theoretical calculations of the relative stabilities of distinct blocking groups instead of the amino- and carboxyl- folded structures for a given protein or of the relative terminating groups of naturally occurring peptides. For the stabilities of distinct M-residue proteins in the same tertiary larger cases we have used the zwitterionic form for initiating and terminating the polypeptide. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" Abbreviations: CRN, crambin; BPTI, bovine pancreatic trypsin in accordance with 18 U.S.C. §1734 solely to indicate this fact. inhibitor; SOD, superoxide dismutase. 11513 Downloaded by guest on October 1, 2021 11514 Biophysics: Head-Gordon et al. Proc. Nad. Acad. Sci. USA 89 (1992) The poly(L-alanine) hypothesis requires demonstrating presented in Section 2 was used to find the secondary that there exists a minimum on the poly(L-alanine) hypersur- structure minimum for the larger polypeptides. face closely mimicking a given protein's native structure. In We have also found poly(L-alanine) minima corresponding Section 3, where we consider supersecondary and tertiary to at least two types of supersecondary structures: the structure of long polypeptides, we will almost always have a parallel 3-sheet-a-helix-parallel 1-sheet (13-a--) and a-he- crystal structure with which to compare the native and the lix-turn-a-helix-turn-a-helix (a-t-a-t-a). For the case of poly(L-alanine) structures. For the secondary structures of a-t-a-t-a, the starting configuration of 30 residues was built small peptides considered in Section 3, we rely on the "by hand," and energy minimized to give this supersecond- adequacy of the all-atom gas phase potential of blocked ary structure type. The initial configuration of the 13-a-f poly(L-alanine) since high-level ab initio studies (7) indicate secondary structure was taken from a subsequence (residues that the all-atom model of alanine dipeptide performs quite 200-249) ofthe crystal structure ofcarboxypeptidase A (14). well structurally and energetically. Nonaliphatic heavy atom centers were given hydrogens so Optimization Techniques. We have used two types of that all hydrogen positions satisfie excluded volume and optimization procedures for finding minima on the potential geometric constraints (6). (Nonpolar hydrogens are repre- energy surfaces described above. For the cases of small sented by an extended version of the aliphatic carbon to peptides (number ofamino acids '10) in secondary structure which they are attached.) The resulting hydrogenated crystal conformations, we have used a quasi-Newton sequential structure was m ed using the penalty finction protocol quadratic programming algorithm (8) with nonlinear con- presented in Section 2. This structure was edited so that the straints. In these cases, five types of constraints were con- backbone atoms and 1-carbon side-chain atoms were re- structed: an L-chirality constraint, a peptide torsion con- tained; for proline and glycine, the backbone hydrogen atom straint (trans or cis), (Cii-N,-CQ,-C,) and T (Ni-Cai-Ci- and 1-carbon side chain were added, respectively, with all Ni+1) constraints appropriate for the secondary structure geometric and steric constraints satisfied. This poly(L- under consideration, and hydrogen bond constraints, again alanine) starting structure was minimized again with the when appropriate for the secondary structure type. The penalty function protocol (Section 2). The rms deviation minimization was started with a structure closely resembling between the native sequence and alanine sequence appears in the secondary structure under consideration and minimized Table 1. with the objective function and the five types of constraints While it is well appreciated that poly(L-alanine) is capable discussed above. The nonlinear constraints were imposed of adopting many different secondary structures, it has not with upper and lower bounds. The optimization was consid- been demonstrated that poly(L-alanine) can mimic wide va- ered converged when the L-chirality dihedral (Cai-Ni-CrCli) rieties of tertiary structure. We now demonstrate that this is constraint of 330 was satisfied to within ±30, the peptide so for the following representative examples: the 46-residue torsion (Cai-Ci-Ni+ICai+i) constraint of00 or 1800 satisfied to protein crambin (CRN) (15), the 58-residue protein bovine within ±100, the backbone dihedrals and T converging to pancreatic trypsin inhibitor (BPTI) (16), the 124-residue within ±0.50 of their secondary structure value, and the protein A (RNase) (17), and the 158-residue protein super- hydrogen bond (O.-Hj) constraint of 1.9 A falling within a oxide dismutase (SOD) (18). window of ±0.4 A. The second stage of the procedure is to All crystal structures were taken from the Protein Data minimize with no constraints starting with the structure Bank (Brookhaven National Laboratory) and supplied with obtained from the constrained first stage. polar hydrogens. The resulting structure was minimized For the cases ofpolypeptides and proteins of >10 residues, using the penalty function protocol described in Section 2 and we have imposed a penalty function protocol for relaxing the cHARmm potential with parameters aroiate for all 20 starting structures into a nearby local minimum.
Load more

Recommended publications
  • Insights Into the Molecular Basis for Substrate Binding and Specificity of the Wild-Type L-Arginine/Agmatine Antiporter Adic
    Insights into the molecular basis for substrate binding and specificity of the wild-type L-arginine/agmatine antiporter AdiC Hüseyin Ilgüa,b,1, Jean-Marc Jeckelmanna,b,1, Vytautas Gapsysc, Zöhre Ucuruma,b, Bert L. de Grootc, and Dimitrios Fotiadisa,b,2 aInstitute of Biochemistry and Molecular Medicine, University of Bern, CH-3012 Bern, Switzerland; bSwiss National Centre of Competence in Research TransCure, University of Bern, CH-3012 Bern, Switzerland; and cComputational Biomolecular Dynamics Group, Max-Planck-Institute for Biophysical Chemistry, D-37077 Goettingen, Germany Edited by Christopher Miller, Howard Hughes Medical Institute, Brandeis University, Waltham, MA, and approved July 26, 2016 (received for review April 4, 2016) Pathogenic enterobacteria need to survive the extreme acidity of Arg-bound states (10). The two outward-open, substrate-free the stomach to successfully colonize the human gut. Enteric bacteria structures are at the reasonable and moderate resolutions of 3.2 Å circumvent the gastric acid barrier by activating extreme acid- (8) and 3.6 Å (9), respectively, and the only ones available of wild- resistance responses, such as the arginine-dependent acid resistance type AdiC (AdiC-wt). The two other structures are with bound system. In this response, L-arginine is decarboxylated to agmatine, Arg and at 3-Å resolution, and could only be obtained as a result thereby consuming one proton from the cytoplasm. In Escherichia of the introduction of specific point mutations: AdiC-N22A (10) coli,theL-arginine/agmatine antiporter AdiC facilitates the export and AdiC-N101A (11). The N101A mutation results in a defective of agmatine in exchange of L-arginine, thus providing substrates for AdiC protein unable to bind Arg and with a dramatically de- further removal of protons from the cytoplasm and balancing the creased turnover rate compared with wild-type (11).
    [Show full text]
  • Separation of Isomers <Emphasis Type="Italic">L </Emphasis>-Alanine and Sarcosine in Urine by Electrospra
    SHORT COMMUNICATION Separation of Isomers L-Alanine and Sarcosine in Urine by Electrospray Ionization and Tandem Differential Mobility Analysis-Mass Spectrometry Pablo Martínez-Lozanoa and Juan Rusb a Institute for Biomedical Technologies-National Research Council, Milan, Italy b SEADM, Valladolid, Spain Sarcosine, an isomer of L-alanine, has been proposed as a prostate cancer progression biomarker [1]. Both compounds are detected in urine, where the measured sarcosine/alanine ratio has been found to be higher in prostate biopsy-positive group versus controls. We present here preliminary evidence showing that urine samples spiked with sarcosine/alanine can be partially resolved in 3 min via tandem differential mobility analysis-mass spectrometry (DMA-MS). Based on the calibration curves obtained for two mobility peaks, we finally estimate their concentration ratio in urine. (J Am Soc Mass Spectrom 2010, 21, 1129–1132) © 2010 American Society for Mass Spectrometry rostate cancer is a leading cause of death among the tive-ion mode at the DMA entrance slit. Our nanospray male population. Sarcosine, an isomer of alanine, parameters were: capillary 360 ␮m o.d., 50 ␮m i.d., length Pwas recently proposed as a prostate cancer progres- 22 cm, driving pressure 75 mbar, and 3.8 kV. The ions sion biomarker [1]. In particular, the sarcosine/alanine entered the separation region propelled by an electric field ratio was found to be significantly higher in urine derived and against a counterflow gas (0.2 L/min). Sheath gas from biopsy-positive prostate cancer patients compared flow was kept constant, and the classification voltage was with biopsy-negative controls.
    [Show full text]
  • Beta Alanine
    PERFORMANCE ENHANCERS FACTS AND BOTTOM LINE BETA ALANINE What is it? B-alanine is a naturally occurring amino acid (a non-essential amino acid) not used by the body to make muscle tissue. Rather, research has shown that B-alanine works by increasing the muscle content of an important compound – carnosine. In fact, the production of carnosine is limited by the availability of B-alanine. Carnosine is highly concentrated in muscle tissue where its role is primarily to soak up hydrogen ions. Does it work? B-alanine is one of the few dietary supplements that actually have good scientific evidence that it can possibly enhance performance. How does it work? When you exercise intensely the body produces hydrogen ions. The longer you exercise the more hydrogen ions you produce and this reduces the pH level in your muscles. Muscles work best in a very specific pH range and when the pH drops below that level then muscular performance also starts to decrease. Anything that helps to prevent or delay that drop in pH will help delay muscle fatigue. This is where B-alanine has proven to be very helpful. Beta-alanine increases the levels of carnosine in your slow and fast twitch muscle fibers and carnosine is a buffer that basically soaks up hydrogen ions and so reduces the drop in pH. By keeping your hydrogen ion levels lower, B-alanine allows you to train harder and longer. The bottom line is that B-alanine works by increasing the hydrogen ion buffering abilities of your muscles. What benefits does it offer? B-alanine has been shown to increase muscle strength, increase muscle mass, increase anaerobic endurance, increase aerobic endurance and increase exercise capacity.
    [Show full text]
  • Alcohol Use Disorder
    Section: A B C D E Resources References Alcohol Use Disorder (AUD) Tool This tool is designed to support primary care providers (family physicians and primary care nurse practitioners) in screening, diagnosing and implementing pharmacotherapy treatments for adult patients (>18 years) with Alcohol Use Disorder (AUD). Primary care providers should routinely offer medication for moderate and severe AUD. Pharmacotherapy alone to treat AUD is better than no therapy at all.1 Pharmacotherapy is most effective when combined with non-pharmacotherapy, including behavioural therapy, community reinforcement, motivational enhancement, counselling and/or support groups. 2,3 TABLE OF CONTENTS pg. 1 Section A: Screening for AUD pg. 7 Section D: Non-Pharmacotherapy Options pg. 4 Section B: Diagnosing AUD pg. 8 Section E: Alcohol Withdrawal pg. 5 Section C: Pharmacotherapy Options pg. 9 Resources SECTION A: Screening for AUD All patients should be screened routinely (e.g. annually or when indicators are observed) with a recommended tool like the AUDIT. 2,3 It is important to screen all patients and not just patients eliciting an index of suspicion for AUD, since most persons with AUD are not recognized. 4 Consider screening for AUD when any of the following indicators are observed: • After a recent motor vehicle accident • High blood pressure • Liver disease • Frequent work avoidance (off work slips) • Cardiac arrhythmia • Chronic pain • Rosacea • Insomnia • Social problems • Rhinophyma • Exacerbation of sleep apnea • Legal problems Special Patient Populations A few studies have reviewed AUD in specific patient populations, including youth, older adults and pregnant or breastfeeding patients. The AUDIT screening tool considered these populations in determining the sensitivity of the tool.
    [Show full text]
  • Amino Acid Chemistry
    Handout 4 Amino Acid and Protein Chemistry ANSC 619 PHYSIOLOGICAL CHEMISTRY OF LIVESTOCK SPECIES Amino Acid Chemistry I. Chemistry of amino acids A. General amino acid structure + HN3- 1. All amino acids are carboxylic acids, i.e., they have a –COOH group at the #1 carbon. 2. All amino acids contain an amino group at the #2 carbon (may amino acids have a second amino group). 3. All amino acids are zwitterions – they contain both positive and negative charges at physiological pH. II. Essential and nonessential amino acids A. Nonessential amino acids: can make the carbon skeleton 1. From glycolysis. 2. From the TCA cycle. B. Nonessential if it can be made from an essential amino acid. 1. Amino acid "sparing". 2. May still be essential under some conditions. C. Essential amino acids 1. Branched chain amino acids (isoleucine, leucine and valine) 2. Lysine 3. Methionine 4. Phenyalanine 5. Threonine 6. Tryptophan 1 Handout 4 Amino Acid and Protein Chemistry D. Essential during rapid growth or for optimal health 1. Arginine 2. Histidine E. Nonessential amino acids 1. Alanine (from pyruvate) 2. Aspartate, asparagine (from oxaloacetate) 3. Cysteine (from serine and methionine) 4. Glutamate, glutamine (from α-ketoglutarate) 5. Glycine (from serine) 6. Proline (from glutamate) 7. Serine (from 3-phosphoglycerate) 8. Tyrosine (from phenylalanine) E. Nonessential and not required for protein synthesis 1. Hydroxyproline (made postranslationally from proline) 2. Hydroxylysine (made postranslationally from lysine) III. Acidic, basic, polar, and hydrophobic amino acids A. Acidic amino acids: amino acids that can donate a hydrogen ion (proton) and thereby decrease pH in an aqueous solution 1.
    [Show full text]
  • Proline- and Alanine-Rich N-Terminal Extension of the Basic Bovine P-Crystallin B1 Chains
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Volume 161, number 2 FEBS 0790 September 1983 Proline- and alanine-rich N-terminal extension of the basic bovine P-crystallin B1 chains G.A.M. Berbers, W.A. Hoekman, H. Bloemendal, W.W. de Jong, T. Kleinschmidt* and G. Braunitzer* Laboratorium voor Biochemie, Universiteit van Nijmegen, Geert Grooteplein Noord 21, 6525 EZ Nijmegen, The Netherlands and *Max-Planck-Institut ft’ir Biochemie, Abteilung Proteinchemie, D-8033 Martinsried bei Miinchen, FRG Received 22 June 1983 The amino acid sequence of the N-terminal region of the two basic bovine &crystallin B1 chains has been analyzed. The results reveal that @Bibis derived in vivo from the primary gene product @la by removal of a short N-terminal sequence. It appears that them1 chains have the same domain structure as observed in other /3- and y-crystallin chains. They have, however, a very long N-terminal extension in comparison with other &chains. This extension is mainly composed of a remarkable Pro- and Ala-rich sequence, which suggests an interaction of these structural proteins with the cytoskeleton and/or the plasma membranes of the lens cells. Protein sequence Bovine &crystallin N-terminal extension Proline- and aianine-rich Domain structure 1. INTRODUCTION 33 000 and 31000, respectively, are characteristic for fltikt, [ 111. ,8Fha is a primary gene product, from The crystallins are evolutionary highly conserv- which ,8&b arises by post-translational modifica- ed structural eye lens proteins, which can be divid; tion [lo-121, most probably a proteolytic step ed into 4 classes: (Y-,,&, y- and t-crystallin [ 11.
    [Show full text]
  • The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats
    W&M ScholarWorks Undergraduate Honors Theses Theses, Dissertations, & Master Projects 4-2017 The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats Justin P. Canakis College of William and Mary Follow this and additional works at: https://scholarworks.wm.edu/honorstheses Part of the Animal Sciences Commons, Exercise Science Commons, Laboratory and Basic Science Research Commons, and the Other Nutrition Commons Recommended Citation Canakis, Justin P., "The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats" (2017). Undergraduate Honors Theses. Paper 1128. https://scholarworks.wm.edu/honorstheses/1128 This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of W&M ScholarWorks. For more information, please contact [email protected]. 1 2 Title Page……………………………………………………………………………………...…..1 Abstract…………………………………………………………………………………………....5 Acknowledgement……………………………………………………………………….………..6 Background.………………………………………………………………………..……………...7 DSEHA and its Effect on the VMS Industry………………...……………………………7 History of Adverse Side Effects from Pre-Workout Supplements ………….……………8 Ingredient Analysis ………………………………………..……………….……………..……....9 2.5g Beta-Alanine…………………………..……………………………………………..9 1g Creatine Nitrate……………………………...……………………………………..…12 500mg L-Leucine……………………………………………………………………...…16 500mg Agmatine Sulfate……………………….………………………………..………18
    [Show full text]
  • The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by College of William & Mary: W&M Publish W&M ScholarWorks Undergraduate Honors Theses Theses, Dissertations, & Master Projects 4-2017 The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats Justin P. Canakis College of William and Mary Follow this and additional works at: https://scholarworks.wm.edu/honorstheses Part of the Animal Sciences Commons, Exercise Science Commons, Laboratory and Basic Science Research Commons, and the Other Nutrition Commons Recommended Citation Canakis, Justin P., "The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats" (2017). Undergraduate Honors Theses. Paper 1128. https://scholarworks.wm.edu/honorstheses/1128 This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of W&M ScholarWorks. For more information, please contact [email protected]. 1 2 Title Page……………………………………………………………………………………...…..1 Abstract…………………………………………………………………………………………....5 Acknowledgement……………………………………………………………………….………..6 Background.………………………………………………………………………..……………...7 DSEHA and its Effect on the VMS Industry………………...……………………………7 History of Adverse Side Effects from Pre-Workout Supplements ………….……………8 Ingredient Analysis ………………………………………..……………….……………..……....9 2.5g Beta-Alanine…………………………..……………………………………………..9
    [Show full text]
  • Detection of Cyanotoxins, Β-N-Methylamino-L-Alanine and Microcystins, from a Lake Surrounded by Cases of Amyotrophic Lateral Sclerosis
    Toxins 2015, 7, 322-336; doi:10.3390/toxins7020322 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Article Detection of Cyanotoxins, β-N-methylamino-L-alanine and Microcystins, from a Lake Surrounded by Cases of Amyotrophic Lateral Sclerosis Sandra Anne Banack 1, Tracie Caller 2,†, Patricia Henegan 3,†, James Haney 4,†, Amanda Murby 4, James S. Metcalf 1, James Powell 1, Paul Alan Cox 1 and Elijah Stommel 3,* 1 Institute for Ethnomedicine, PO Box 3464, Jackson, WY 83001, USA; E-Mails: [email protected] (S.A.B.); [email protected] (J.S.M.); [email protected] (J.P.); [email protected] (P.A.C.) 2 Cheyenne Regional Medical Group, Cheyenne, WY 82001, USA; E-Mail: [email protected] 3 Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA; E-Mail: [email protected] 4 Department of Biological Sciences, University of New Hampshire, Durham, NH 03824, USA; E-Mails: [email protected] (J.H.); [email protected] (A.M.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-603-650-8615; Fax: +1-603-650-6233. Academic Editor: Luis M. Botana Received: 19 November 2014 / Accepted: 21 January 2015 / Published: 29 January 2015 Abstract: A cluster of amyotrophic lateral sclerosis (ALS) has been previously described to border Lake Mascoma in Enfield, NH, with an incidence of ALS approximating 25 times expected. We hypothesize a possible association with cyanobacterial blooms that can produce β-N-methylamino-L-alanine (BMAA), a neurotoxic amino acid implicated as a possible cause of ALS/PDC in Guam.
    [Show full text]
  • Monopeptide Versus Monopeptoid: Insights on Structure and Hydration of Aqueous Alanine and Sarcosine Via X-Ray Absorption Spectroscopy
    4702 J. Phys. Chem. B 2010, 114, 4702–4709 Monopeptide versus Monopeptoid: Insights on Structure and Hydration of Aqueous Alanine and Sarcosine via X-ray Absorption Spectroscopy Janel S. Uejio,†,‡ Craig P. Schwartz,†,‡ Andrew M. Duffin,†,‡ Alice England,†,‡ David Prendergast,§ and Richard J. Saykally*,†,‡ Department of Chemistry, UniVersity of California, Berkeley, California 94720-1460 and Chemical Sciences DiVision, Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, California 94720 ReceiVed: NoVember 19, 2009; ReVised Manuscript ReceiVed: March 3, 2010 Despite the obvious significance, the aqueous interactions of peptides remain incompletely understood. Their synthetic analogues called peptoids (poly-N-substituted glycines) have recently emerged as a promising biomimetic material, particularly due to their robust secondary structure and resistance to denaturation. We describe comparative near-edge X-ray absorption fine structure spectroscopy studies of aqueous sarcosine, the simplest peptoid, and alanine, its peptide isomer, interpreted by density functional theory calculations. The sarcosine nitrogen K-edge spectrum is blue shifted with respect to that of alanine, in agreement with our calculations; we conclude that this shift results primarily from the methyl group substitution on the nitrogen of sarcosine. Our calculations indicate that the nitrogen K-edge spectrum of alanine differs significantly between dehydrated and hydrated scenarios, while that of the sarcosine zwitterion is less affected by hydration. In contrast, the computed sarcosine spectrum is greatly impacted by conformational variations, while the alanine spectrum is not. This relates to a predicted solvent dependence for alanine, as compared to sarcosine. Additionally, we show the theoretical nitrogen K-edge spectra to be sensitive to the degree of hydration, indicating that experimental X-ray spectroscopy may be able to distinguish between bulk and partial hydration, such as found in confined environments near proteins and in reverse micelles.
    [Show full text]
  • Alcoholic Liver Disease Your Role Is Essential in Preventing, Detecting, and Co-Managing Alcoholic Liver Disease in Inpatient and Ambulatory Settings
    Preventing drinking relapse in patients with alcoholic liver disease Your role is essential in preventing, detecting, and co-managing alcoholic liver disease in inpatient and ambulatory settings Gerald Scott Winder, MD lcohol use disorder (AUD) is a mosaic of psychiatric and Assistant Professor medical symptoms. Alcoholic liver disease (ALD) in its acute Department of Psychiatry University of Michigan Health System and chronic forms is a common clinical consequence of long- Ann Arbor, Michigan A standing AUD. Patients with ALD require specialized care from pro- Jessica Mellinger, MD, MSc fessionals in addiction, gastroenterology, and psychiatry. However, Clinical Lecturer medical specialists treating ALD might not regularly consider medi- Department of Internal Medicine University of Michigan Health System cations to treat AUD because of their limited experience with the Ann Arbor, Michigan drugs or the lack of studies in patients with significant liver disease.1 Robert J. Fontana, MD Similarly, psychiatrists might be reticent to prescribe medications for Professor of Medicine AUD, fearing that liver disease will be made worse or that they will Division of Gastroenterology cause other medical complications. As a result, patients with ALD Department of Internal Medicine University of Michigan Health System might not receive care that could help treat their AUD (Box, page 24). Ann Arbor, Michigan Given the high worldwide prevalence and morbidity of ALD,2 gen- Disclosures eral and subspecialized psychiatrists routinely evaluate patients with Dr. Winder and Dr. Mellinger report no financial AUD in and out of the hospital. This article aims to equip a psychia- relationships with any company whose products are mentioned in this article or with manufacturers of trist with: competing products.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,777,074 B2 Kramer Et Al
    US007777074 B2 (12) United States Patent (10) Patent No.: US 7,777,074 B2 Kramer et al. (45) Date of Patent: Aug. 17, 2010 (54) AMINO ACID COMPOUNDS (52) U.S. Cl. .................................... 562/512:548/335.5 (58) Field of Classification Search ................. 514/400, (75) Inventors: Ronald Kramer, Phoenix, AZ (US); 514/561, 563: 548/335.5; 562/512 hander Nikolaidis, New Kallikratia See application file for complete search history. GR (56) References Cited (73) Assignee: Estol,Inisational LLC, OTHER PUBLICATIONS Mostad et al., 1986, CAS: 104:197543.* (*) Notice: Subject to any disclaimer, the term of this Pradhan et al. publication, Journal of Chemical and Engineering patent is extended or adjusted under 35 Data, 2000, 45(1): 140-143.* U.S.C. 154(b) by 58 days. * cited by examiner (21) Appl. No.: 11/950,273 Primary Examiner Rei-tsang Shiao (22) Filed: Dec. 4, 2007 (74) Attorney, Agent, or Firm Booth Udall, PLC (65) Prior Publication Data (57) ABSTRACT US 2009/007611.0 A1 Mar. 19, 2009 An Amino Acid Compound is described. The Amino Acid Related U.S. Application Data Compound may comprise an Amino Acid and one of a Nitrate (60) Provisional application No. 60/973.229, filed on Sep. and a Nitrite. The Amino Acid may be one of Agmatine, 18, 2007 Arginine, Beta Alanine, Citrulline, Creatine, Glutamine, s L-Histidine, Isoleucine, Leucine, Norvaline, Ornithine, and (51) Int. Cl. Valine. C07C 53/00 (2006.01) CO7D 233/6 (2006.01) 2 Claims, No Drawings US 7,777,074 B2 1. 2 AMINO ACID COMPOUNDS of an Amino Acid Compound comprising an Amino Acid and one of a Nitrate and a Nitrite to the human or animal.
    [Show full text]